Raoufinia R, Afrasiabi P, Dehghanpour A, Memarpour S, Sayyed Hosseinian S, Saburi E
Microrna. 2024; 13(3):175-201.
PMID: 39005129
DOI: 10.2174/0122115366298799240625115843.
Ferrer-Diaz A, Sinha G, Petryna A, Gonzalez-Bermejo R, Kenfack Y, Adetayo O
Cell Commun Signal. 2024; 22(1):119.
PMID: 38347590
PMC: 10863086.
DOI: 10.1186/s12964-024-01512-1.
Orcajo-Rincon J, Munoz-Langa J, Sepulveda-Sanchez J, Fernandez-Perez G, Martinez M, Noriega-Alvarez E
Clin Transl Oncol. 2022; 24(7):1290-1310.
PMID: 35152355
PMC: 9192443.
DOI: 10.1007/s12094-022-02784-0.
Ahmed S, Kamal S, Salah T, Sedik M, Youssief A
J Bone Oncol. 2021; 31:100395.
PMID: 34712554
PMC: 8529095.
DOI: 10.1016/j.jbo.2021.100395.
Alsadi N, Mallet J, Matar C
J Cancer Prev. 2021; 26(3):162-173.
PMID: 34703819
PMC: 8511576.
DOI: 10.15430/JCP.2021.26.3.162.
The Role of Autophagy and lncRNAs in the Maintenance of Cancer Stem Cells.
Jahangiri L, Ishola T, Pucci P, Trigg R, Pereira J, Williams J
Cancers (Basel). 2021; 13(6).
PMID: 33799834
PMC: 7998932.
DOI: 10.3390/cancers13061239.
Targeting Dormant Ovarian Cancer Cells and in an Mouse Model of Platinum Resistance.
Huang Z, Kondoh E, Visco Z, Baba T, Matsumura N, Dolan E
Mol Cancer Ther. 2020; 20(1):85-95.
PMID: 33037137
PMC: 11562011.
DOI: 10.1158/1535-7163.MCT-20-0119.
Immune vulnerability of ovarian cancer stem-like cells due to low CD47 expression is protected by surrounding bulk tumor cells.
Chang C, Wu C, Hsu Y, Hsu Y
Oncoimmunology. 2020; 9(1):1803530.
PMID: 32923164
PMC: 7458642.
DOI: 10.1080/2162402X.2020.1803530.
Overexpression of Cosmc suppresses cell migration and invasion in different subtypes of breast cancer cells via Tn and T glycans.
Liu J, Xu F, Li J, Jiang H
Biosci Rep. 2020; 40(6).
PMID: 32452513
PMC: 7300286.
DOI: 10.1042/BSR20191062.
Cellular Plasticity in Breast Cancer Progression and Therapy.
Kong D, Hughes C, Ford H
Front Mol Biosci. 2020; 7:72.
PMID: 32391382
PMC: 7194153.
DOI: 10.3389/fmolb.2020.00072.
Metastasis-initiating cells induce and exploit a fibroblast niche to fuel malignant colonization of the lungs.
Pein M, Insua-Rodriguez J, Hongu T, Riedel A, Meier J, Wiedmann L
Nat Commun. 2020; 11(1):1494.
PMID: 32198421
PMC: 7083860.
DOI: 10.1038/s41467-020-15188-x.
The natural adaptive evolution of cancer: The metastatic ability of cancer cells.
Olteanu G, Mihai I, Bojin F, Gavriliuc O, Paunescu V
Bosn J Basic Med Sci. 2020; 20(3):303-309.
PMID: 32020846
PMC: 7416172.
DOI: 10.17305/bjbms.2019.4565.
Functional outcome of operative treatment for pelvic metastatic bone disease from primary thyroid cancer: A case series.
Prabowo Y, Asril E, Wikanjaya R
Int J Surg Case Rep. 2020; 66:288-297.
PMID: 31891891
PMC: 6938941.
DOI: 10.1016/j.ijscr.2019.11.065.
Metastatic Latency, a Veiled Threat.
Kim K, Marquez-Palencia M, Malladi S
Front Immunol. 2019; 10:1836.
PMID: 31447846
PMC: 6691038.
DOI: 10.3389/fimmu.2019.01836.
Autophagy inhibition elicits emergence from metastatic dormancy by inducing and stabilizing Pfkfb3 expression.
Flynn A, Calhoun B, Sharma A, Chang J, Almasan A, Schiemann W
Nat Commun. 2019; 10(1):3668.
PMID: 31413316
PMC: 6694140.
DOI: 10.1038/s41467-019-11640-9.
Impacts of Cytochrome P450 2D6 (CYP2D6) Genetic Polymorphism in Tamoxifen Therapy for Breast Cancer.
Soares Bezerra L, Santos-Veloso M, Bezerra Junior N, da Fonseca L, Sales W
Rev Bras Ginecol Obstet. 2018; 40(12):794-799.
PMID: 30536272
PMC: 10316940.
DOI: 10.1055/s-0038-1676303.
Oncological safety of autologous breast reconstruction after mastectomy for invasive breast cancer.
Geers J, Wildiers H, Van Calster K, Laenen A, Floris G, Vandevoort M
BMC Cancer. 2018; 18(1):994.
PMID: 30340548
PMC: 6194715.
DOI: 10.1186/s12885-018-4912-6.
Cancer stem cell populations in lymphoma in dogs and impact of cytotoxic chemotherapy.
Hartley G, Elmslie R, Murphy B, Hopkins L, Guth A, Dow S
Vet Comp Oncol. 2018; 17(1):69-79.
PMID: 30238600
PMC: 6364829.
DOI: 10.1111/vco.12447.
Investigating the Impact of a Primary Tumor on Metastasis and Dormancy Using MRI: New Insights into the Mechanism of Concomitant Tumor Resistance.
Hamilton A, Parkins K, Murrell D, Ronald J, Foster P
Tomography. 2018; 2(2):79-84.
PMID: 30042958
PMC: 6024418.
DOI: 10.18383/j.tom.2016.00151.
Novel triple‑positive markers identified in human non‑small cell lung cancer cell line with chemotherapy-resistant and putative cancer stem cell characteristics.
Abdul Satar N, Fakiruddin K, Lim M, Mok P, Zakaria N, Fakharuzi N
Oncol Rep. 2018; 40(2):669-681.
PMID: 29845263
PMC: 6072294.
DOI: 10.3892/or.2018.6461.